ADVFN Logo ADVFN
Donnée du Marché
Actualité
Outils
Donnée du Marché
Discover

Hot Features

Follow Feed

Rester connecter avec les traders et investisseurs dans notre communauté Follow Feed.

Flux des Options

Explorez des données complètes sur les options et utilisez les filtres avancés avec Options Flow.

Moniteur

Organisez et surveillez vos d'actions et actifs avec le Moniteur.
Se connecter Premium IconPremium Help Menu
CAC 40
8 007,62
1,47%
Dow Jones
44 731,60
-0,32%
DAX
21 902,42
1,63%
Brent Oil
74,335
-0,33%
Bitcoin
96 677,33
0,07%
Registration Strip Icon for discussion Inscrivez-vous pour interagir sur nos forums actifs pour discuter avec des investisseurs aux idées similaires.
S'inscrire
  1. Accueil
  2. Investir
  3. Actions
  4. Etats-Unis
  5. NASDAQ

  6. Pacira BioSciences Inc (PCRX) Cours

Pacira BioSciences Inc

Pacira BioSciences Inc (PCRX)

PharmaCorp RX Inc
26,82
-0,27
( -1,00% )
Mis à jour : 18:18:05
Retardé de 15 minutes

Outils de qualité professionnelle, pour des investisseurs individuels.

Premium

Statistiques et détails clés

Dernier
26,82
Prix Achat
26,77
Prix Vente
26,83
Volume échangé
147 154
26,71 Fourchette du Jour 27,17
11,26 Plage de 52 semaines 31,67
Cap du marché
1,238B
Clôture Veille
27,09
Ouverture
27,17
Dernière Transaction
4
@
26.7887
Dernière heure de transaction
18:18:20
Volume financier
US$ 3 968 013
VWAP
26,965
Volume moyen (3 m)
811 627
Actions en circulation
46 173 240
Rendement du Dividende
-
Ratio Cours sur Bénéfices
29,50
Bénéfice par action (BPA)
0,91
Chiffre d'affairess
678,4M
Bénéfice net
41,96M

À propos de Pacira BioSciences Inc

Pacira BioSciences Inc is a provider of non-opioid pain management and regenerative health solutions dedicated to advancing and improving outcomes for health care practitioners and their patients. The company has launched EXPAREL which utilizes DepoFoam, a product delivery technology that encapsulat... Pacira BioSciences Inc is a provider of non-opioid pain management and regenerative health solutions dedicated to advancing and improving outcomes for health care practitioners and their patients. The company has launched EXPAREL which utilizes DepoFoam, a product delivery technology that encapsulates drugs without altering their molecular structure, and releases them over a desired period of time. Show more

Secteur
Pharmaceutical Preparations
Industrie
Pharmaceutical Preparations
Site Web
www.pacira.com
Siège social
Wilmington, Delaware, USA
Fondé
-
Pacira BioSciences Inc est coté dans le secteur Pharmaceutical Preparations de la NASDAQ avec le ticker PCRX. Le dernier cours de clôture d'Pacira BioSciences était de US$27,09. Au cours de la dernière année, les actions de Pacira BioSciences ont été négociées dans une fourchette de prix de US$ 11,26 à US$ 31,67.

Pacira BioSciences compte actuellement 46 173 240 actions en circulation. La capitalisation boursière d'Pacira BioSciences est de US$1,25 milliard. Pacira BioSciences a un ratio cours/bénéfice (ratio PE) de 29.50.

PCRX Dernières nouvelles

Plus de nouvelles

Pacira BioSciences Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

PARSIPPANY, N.J., Feb. 06, 2025 (GLOBE NEWSWIRE) -- Pacira BioSciences, Inc. (Nasdaq: PCRX), the industry leader in the delivery of innovative, non-opioid pain therapies to transform the lives...

il y a 5 heures
GlobeNewswire Inc.

The Gross Law Firm Notifies Shareholders of Pacira BioSciences, Inc.(PCRX) of a Class Action Lawsuit and an Upcoming Deadline

The Gross Law Firm Notifies Shareholders of Pacira BioSciences, Inc.(PCRX) of a Class Action Lawsuit and an Upcoming Deadline PR Newswire NEW YORK, Feb. 6, 2025 NEW YORK, Feb. 6, 2025...

il y a 7 heures
PR Newswire (US)

Form 4 - Statement of changes in beneficial ownership of securities

05 Février 2025
Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities

05 Février 2025
Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities

05 Février 2025
Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities

05 Février 2025
Edgar (US Regulatory)

The Gross Law Firm Announces the Filing of a Securities Class Action on Behalf of Pacira BioSciences, Inc.(PCRX) Shareholders

The Gross Law Firm Announces the Filing of a Securities Class Action on Behalf of Pacira BioSciences, Inc.(PCRX) Shareholders PR Newswire NEW YORK, Feb. 3, 2025 NEW YORK, Feb. 3, 2025...

03 Février 2025
PR Newswire (US)

Form 8-K - Current report

30 Janvier 2025
Edgar (US Regulatory)

Pacira Announces Updates to Board of Directors

-- Accomplished Business and Financial Leader, Laura Brege, Appointed Chair -- -- Paul J. Hastings and Andreas Wicki, PhD Retire from Board of Directors -- PARSIPPANY, N.J., Jan. 30, 2025...

30 Janvier 2025
GlobeNewswire Inc.

The Gross Law Firm Notifies Shareholders of Pacira BioSciences, Inc. (PCRX) of a Class Action Lawsuit and an Upcoming Deadline

The Gross Law Firm Notifies Shareholders of Pacira BioSciences, Inc. (PCRX) of a Class Action Lawsuit and an Upcoming Deadline PR Newswire NEW YORK, Jan. 30, 2025 NEW YORK, Jan. 30, 2025...

30 Janvier 2025
PR Newswire (US)
PériodeVariationVariation %Ouver.HautBasMoyenne Vol. Quot.VWAP
1-0.18-0.6666666666672727.5925.0685726626.41100345CS
46.7733.765586034920.0527.5920.0195889923.93167681CS
1210.3662.940461725416.4627.591681162720.55781048CS
266.4231.470588235320.427.5911.2694554416.81565408CS
52-4.3-13.817480719831.1231.6711.2688148521.24197583CS
156-37.45-58.269799284364.2782.1611.2663446034.52941006CS
260-18.4-40.689960194645.2282.1611.2658863441.96719624CS

PCRX - Frequently Asked Questions (FAQ)

What is the current Pacira BioSciences share price?
The current share price of Pacira BioSciences is US$ 26,82
How many Pacira BioSciences shares are in issue?
Pacira BioSciences has 46 173 240 shares in issue
What is the market cap of Pacira BioSciences?
The market capitalisation of Pacira BioSciences is USD 1,25B
What is the 1 year trading range for Pacira BioSciences share price?
Pacira BioSciences has traded in the range of US$ 11,26 to US$ 31,67 during the past year
What is the PE ratio of Pacira BioSciences?
The price to earnings ratio of Pacira BioSciences is 29,5
What is the cash to sales ratio of Pacira BioSciences?
The cash to sales ratio of Pacira BioSciences is 1,82
What is the reporting currency for Pacira BioSciences?
Pacira BioSciences reports financial results in USD
What is the latest annual turnover for Pacira BioSciences?
The latest annual turnover of Pacira BioSciences is USD 678,4M
What is the latest annual profit for Pacira BioSciences?
The latest annual profit of Pacira BioSciences is USD 41,96M
What is the registered address of Pacira BioSciences?
The registered address for Pacira BioSciences is 1209 ORANGE STREET, WILMINGTON, DELAWARE, 19801
What is the Pacira BioSciences website address?
The website address for Pacira BioSciences is www.pacira.com
Which industry sector does Pacira BioSciences operate in?
Pacira BioSciences operates in the PHARMACEUTICAL PREPARATIONS sector

Moteurs

Voir tout
  • Volume
  • % Gagnants
  • % Perdants
SymbolePrixVol.
QNTMQuantum Biopharma Ltd
US$ 17,36
(102,33%)
28,72M
LTRYLottery com Inc
US$ 0,9455
(93,00%)
155,35M
APPSDigital Turbine Inc
US$ 4,515
(77,76%)
85,8M
LIPOLipella Pharmaceuticals Inc
US$ 4,41
(70,93%)
73,7M
INVZWInnoviz Technologies Ltd
US$ 0,15
(65,56%)
145,53k
RETOReTo Eco Solutions Inc
US$ 0,4947
(-38,16%)
614,01k
SDASunCar Technology Group Inc
US$ 5,36
(-36,49%)
2,83M
AVGRAvinger Inc
US$ 0,38395
(-31,43%)
1,05M
SRTSSensus Healthcare Inc
US$ 6,1999
(-31,04%)
1,81M
CRMLCritical Metals Corporation
US$ 6,19
(-29,01%)
724,64k
MGOLMGO Global Inc
US$ 0,1897
(36,47%)
257,43M
LTRYLottery com Inc
US$ 0,9455
(93,00%)
155,35M
NVDANVIDIA Corporation
US$ 127,34
(2,01%)
128,32M
CYNCYNGN Inc
US$ 0,0784
(-4,39%)
102,29M
RIMEAlgorhythm Holdings Inc
US$ 0,02175
(4,07%)
91,48M

Forums

Afficher les forums
Aucune Discussion Trouvée
Ajouter une Discussion

Dernières Valeurs Consultées

NASDAQ
PCRX
Pacira BioSciences
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

France
Société
Entreprise
Popular
Obtenir l'application
App Store
Google Play

Assistance: support@advfn.fr

En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales

© 2025 ADVFN PLC - Tous droits réservés

Supprimer les publicités

Inscrivez-vous pour une expérience sans publicité

Aucune publicité

Essayez maintenant

Conserver les annonces